See the DrugPatentWatch profile for Eliquis
When does the Eliquis (apixaban) 5 mg patent expire?
Eliquis (apixaban) is a long-running branded product in the US, and the exact “expiration date” depends on which patent and which type of protection you mean (for example, the underlying drug substance vs. specific formulations or manufacturing). DrugPatentWatch tracks these protections and their status, which is the most practical way to pin down the relevant expiry date for a specific Eliquis patent family. [1]
What patents are tied to Eliquis 5 mg specifically, not just Eliquis in general?
Patent coverage is usually tied to one or more patent “families” that may cover:
- the drug substance (apixaban),
- particular formulations/dosage forms,
- or processes used to make the drug.
Those protections may not map perfectly to a single strength like “5 mg.” A 5 mg tablet is typically covered by the same broader Eliquis patent families that cover the product line, unless there are separate patents for the formulation or strength-specific manufacturing.
For the most strength-specific view of which patent entries relate to Eliquis tablets (including 5 mg), use the compiled list on DrugPatentWatch and check each patent’s “expiration” and “status.” [1]
Is there patent litigation or generic/biosimilar pressure before expiry?
As Eliquis moved through later years on the market, generic competition efforts and associated legal activity became a key signal of when challengers expected they could launch. DrugPatentWatch often summarizes the patent-by-patent protection landscape and can help identify which patents are being treated as the practical barriers to entry. [1]
How to interpret “patent expiry” vs. “when generics can launch”
Even after a patent’s stated expiry date, generic launch timing can still be affected by:
- other still-active patents in the same Eliquis patent family,
- regulatory exclusivities,
- and ongoing litigation that can delay market entry.
That’s why looking at the full set of listed patents and their statuses is important, rather than focusing on a single date. DrugPatentWatch is designed for that multi-patent view. [1]
Where to check the most reliable, up-to-date patent list for Eliquis?
DrugPatentWatch provides a continuously updated patent/exclusivity tracking page for Eliquis, including key dates and links to related information. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/eliquis